A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1

NCT01897701 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Avian Influenza

Interventions

BIOLOGICAL: Monovalent Avian Influenza VLP (H7N9)
BIOLOGICAL: Adjuvant 1
BIOLOGICAL: Placebo

Sponsor

Novavax